At the most recent session of the World Health Assembly, global health leaders convened to address a series of urgent and converging challenges. From the persistent threat of tuberculosis (TB) to the rising burden of noncommunicable diseases (NCDs) and the corrosive impact of health-related disinformation, member states moved to formalize strategies that prioritize long-term resilience, equity, and evidence-based policy. The proceedings marked a significant turning point in how international bodies intend to manage both centuries-old infectious killers and the modern-day metabolic health crisis.
I. Charting the Future: A Post-2030 Strategy to End Tuberculosis
Despite monumental progress, tuberculosis remains one of the world’s most lethal infectious diseases. Recognizing that current efforts, while successful in saving millions, are falling short of the 2030 Sustainable Development Goals (SDGs), the Assembly formally requested that the WHO Director-General develop a comprehensive post-2030 TB strategy.
The Evolution of the TB Response
The decision to draft a new roadmap—to be presented at the Eighty-first World Health Assembly in 2028—reflects a pragmatic shift. While the current "End TB Strategy" has been instrumental, global targets are currently off-track. The data is a study in contrasts: between 2000 and 2024, concerted global efforts saved an estimated 83 million lives. Furthermore, 2024 saw the first post-pandemic decline in TB incidence alongside the highest recorded levels of access to essential services.
However, these gains are fragile. Persistent challenges—including chronic underfunding, the lingering aftershocks of the COVID-19 pandemic, geopolitical conflict, climate-related displacement, and systemic inequality—continue to fuel the spread of the disease. The post-2030 strategy is intended to be more than just a continuation of previous policies; it is designed to integrate TB care into the broader architecture of primary health care, universal health coverage, and global health security.
II. Addressing the Growing Burden of Steatotic Liver Disease (SLD)
In a significant move to address the burgeoning NCD crisis, the Assembly adopted a landmark resolution recognizing steatotic liver disease (SLD)—formerly known as fatty liver disease—as a major public health priority. With an estimated 1.7 billion people affected globally, SLD is now one of the fastest-growing causes of chronic liver disease, acting as a silent driver of disability and death.
The Metabolic Link
SLD does not exist in a vacuum. It is inextricably linked to the global rise in obesity, type 2 diabetes, and cardiovascular diseases. The Assembly’s resolution underscores that without robust preventative action, the progression from SLD to fibrosis, cirrhosis, and ultimately liver cancer will place an unsustainable burden on health systems worldwide.
The resolution mandates a multi-faceted approach:
- National Integration: Countries are urged to weave SLD prevention and management into their existing NCD strategies.
- Primary Care Empowerment: Strengthening primary health care to ensure early screening and diagnosis, particularly for children and adolescents.
- Multisectoral Action: Addressing the root causes, such as unhealthy diets, physical inactivity, and the harmful consumption of alcohol.
The WHO has been tasked with providing technical support to member states and reporting on progress biennially, ensuring that SLD remains a permanent fixture on the global health agenda.
III. Equity for the Underserved: Haemophilia and Bleeding Disorders
Perhaps the most poignant moment of the Assembly was the commitment to the community living with haemophilia and other bleeding disorders. These conditions, which impair the body’s ability to clot blood, have long been marginalized in global health discourse. With approximately 70% of those living with haemophilia worldwide remaining undiagnosed, the Assembly’s new resolution serves as a vital correction to a long-standing equity gap.
A Commitment to Life-Saving Care
The resolution calls for the integration of bleeding disorder management into broader national health policies, including maternal health and primary care. Beyond simple recognition, the resolution advocates for:
- Essential Medicine Inclusion: Urging member states to include life-saving factor concentrates and novel non-factor therapies in their National Essential Medicines Lists.
- Infrastructure Development: Strengthening diagnostic capacity and facilitating timely referrals to specialized treatment centers.
- Data and Advocacy: Promoting national data collection to better understand the scope of the problem and launching awareness campaigns to dismantle the stigma that prevents many from seeking care.
IV. The Strategic Roundtable: Combating the Infodemic
Perhaps the most modern threat discussed at the Assembly was the proliferation of health mis- and disinformation. A high-level Strategic Roundtable brought together government officials, tech sector representatives, civil society, and youth advocates to declare that the integrity of information is a prerequisite for the integrity of health systems.
Information as a Public Health Tool
The consensus reached was clear: mis- and disinformation are not merely communication hurdles; they are public health threats that undermine the delivery of life-saving interventions, such as vaccines and essential treatments.
Key takeaways from the discussion included:
- Moving Beyond Correction: The need to pivot from reactive fact-checking to proactive engagement.
- Building Trust: Information ecosystems must be resilient, transparent, and built on trust. This involves empowering frontline health workers to act as "information anchors" within their communities.
- Collaborative Governance: The Assembly highlighted the need for a "whole-of-government" approach that involves technology platforms, media, and scientific networks working in lockstep to ensure evidence-based information reaches the public in real-time.
V. Chronology of Policy Development
- 2000–2024: The era of the End TB Strategy; 83 million lives saved despite significant disruptions from the global pandemic.
- May 2026 (WHA79): The strategic roundtable on disinformation sets the stage for a new era of proactive communication.
- Early 2028: Deadline for the development of the post-2030 TB strategy in consultation with global stakeholders.
- May 2028 (WHA81): Submission of the post-2030 TB strategy for formal endorsement.
VI. Implications and Future Outlook
The collective actions taken by the World Health Assembly represent a shift toward integrated health governance. By linking TB control to universal health coverage and folding SLD management into NCD agendas, the WHO is signaling a move away from "siloed" disease management.
Economic and Social Impact
The economic implications of these resolutions are substantial. By investing in early diagnosis for conditions like SLD and bleeding disorders, nations can avoid the exorbitant long-term costs of late-stage care, such as liver transplants or emergency surgery for unmanaged hemorrhages.
However, the success of these resolutions rests entirely on implementation. The "off-track" status of the 2030 Agenda for Sustainable Development serves as a sobering reminder that policy endorsements do not automatically translate into on-the-ground outcomes. Success will require sustained political will, consistent funding, and a commitment to the "information integrity" discussed during the Strategic Roundtable.
As the world looks toward 2028, the message from the Assembly is one of measured urgency. Whether dealing with the oldest infectious diseases or the newest digital threats, the global health community is acknowledging that isolation is no longer a viable strategy. The future of health security depends on the convergence of science, policy, and public trust.
Conclusion
The World Health Assembly has successfully laid the groundwork for a more inclusive and resilient global health architecture. By addressing the needs of the haemophilia community, confronting the rise of liver disease, and preparing a forward-looking TB strategy, member states have reaffirmed their commitment to the core mission of the WHO. The challenge remains to bridge the gap between these high-level commitments and the daily reality of patients in every corner of the globe. As the clock ticks toward 2030, the ability of these nations to act in concert will determine the health outcomes of the next generation.
About the Author
